#AANAM – Givlaari Reduces Pain, Lowers Pain Killer Use in AHP

#AANAM – Givlaari Reduces Pain, Lowers Pain Killer Use in AHP

292604

#AANAM – Givlaari Reduces Pain, Lowers Pain Killer Use in AHP

Six months of treatment with Givlaari (givosiran) effectively reduced pain during and between porphyria attacks in people with acute hepatic porphyria (AHP), also known as acute porphyria, according to a post-hoc analysis of data from the Phase 3 ENVISION trial. Givlaari also was found to lower the use of pain killers (analgesics) among acute porphyria patients, the data show. These findings add to top-line data from the study, which showed that the therapy significantly reduced the…

You must be logged in to read/download the full post.